Hydroxychloroquine's Efficacy as an Antiplatelet Agent Study in Healthy Volunteers: A Proof of Concept Study

Conclusion: This study suggests that HCQ has antiplatelet properties possibly through the AA pathway (downstream to thromboxane A2 production). With possible additional beneficial effects over the traditional CVD risk factors, larger studies in the future might explore HCQ’s potential as an antiplatelet agent.

http://cpt.sagepub.com/cgi/content/abstract/20/2/174?rss=1

Source: Journal of Cardiovascular Pharmacology and Therapeutics - February 9, 2015 Category: Cardiology Authors: Achuthan, S., Ahluwalia, J., Shafiq, N., Bhalla, A., Pareek, A., Chandurkar, N., Malhotra, S. Tags: Clinical Studies Source Type: research